FEASIBILITY/TOXICITY AND RESPONSE OF UPFRONT 131I-MIBG THERAPY FOLLOWED BY STANDARD ARM GPOH NB 2004 PROTOCOL IN NEWLY DIAGNOSED HIGH-RISK NEUROBLASTOMA PATIENTS

PEDIATRIC BLOOD & CANCER(2015)

Cited 0|Views4
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined